ACTRN12610000528055
Not yet recruiting
未知
In patients with acute decompensated heart failure does continuous positive airway pressure compared to oxygen or standard medical therapy result in improved lung function?
Professor Matthew Naughton0 sites60 target enrollmentJune 30, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Professor Matthew Naughton
- Enrollment
- 60
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with an acute exacerbation of their heart failure
- •Previous diagnosis of heart failure based on echocardiography
- •Stable clincial status: respiratory rate \<35 bpm, oxygen saturation via pulse oximeter(SpO2\) \> or equal to 85% on room air, systolic blood pressure \> 90mmHg, clinically well perfused and able to speak in sentences
- •Co\-operative and able to give consent
Exclusion Criteria
- •History of lung disease requireing treatment \> 4 weeks
- •Severe renal (requiring dialysis) or neurological disease
- •Recent myocardial infarction (\<6 weeks)
- •Requiring itravenous inotropes
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Acute decompensated heart failure: slingle-center retrospective cohort studyacute decompensated heart failureJPRN-UMIN000035989Showa University Northern Yokohama Hospital500
Completed
Not Applicable
Cardiac dysfunction and undiagnosed heart failure in women as a long term effect of the treatment of breast cancer in an unselected primary care settingcardiac dysfunctionheart failure1008220610018865NL-OMON39592niversitair Medisch Centrum Groningen700
Completed
Not Applicable
Acute Decompensated Heart Failure Syndromes Registry in Japan Multicenter prospective observational cohort studyAcute decompensated heart failure syndromesJPRN-UMIN000000736ATTEND registry committee10,000
Completed
Not Applicable
Heart failure revascularisatioHeart failure with left ventricular systolic dysfunctionCirculatory SystemISRCTN86284615Medical Research Council (MRC) (UK)800
Active, not recruiting
Not Applicable
Survival of patients with acute heart failure in need of intravenous inotropic support; a multicentre parallel- group, randomised, double- blind, double- dummy study of levosimendan versus dobutamine in patients with acute heart failure. - The SURVIVE studyEUCTR2004-001225-16-ATOrion Pharma700